Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel K Hopper

Showing results (11-20 of 59) with videos related to

Pageof 6
Sort By:
American Journal of Medical Genetics. Part A|February 24, 2015
Neonatal pulmonary arterial hypertension and Noonan syndrome: two fatal cases with a specific RAF1 mutationRachel K Hopper, Jeffrey A Feinstein, Melanie A Manning, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 12, 2017
Subcutaneous treprostinil in pediatric patients with failing single-ventricle physiologyStephanie S Handler, Michelle T Ogawa, Rachel K Hopper, et al.
Pulmonary Circulation|January 9, 2018
Central line replacement following infection does not improve reinfection rates in pediatric pulmonary hypertension patients receiving intravenous prostanoid therapyElisa K McCarthy, Michelle T Ogawa, Rachel K Hopper, et al.
Pulmonary Circulation|February 13, 2024
Younger age at initiation of subcutaneous treprostinil is associated with better response in pediatric Group 1 pulmonary arterial hypertensionJustin J Kochanski, Jeffrey A Feinstein, Michelle Ogawa, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|February 16, 2026
Results of a pulmonary hypertension screening program for premature infants with bronchopulmonary dysplasiaRamya Ramachandra, Alisa Arunamata, Amanda Moy, et al.
Pulmonary Circulation|April 15, 2025
Importance of age at diagnosis of pulmonary hypertension in children living at high altitude: Longitudinal follow-up of 86 patientsGabriel F Diaz, Carlos E Diaz-Castrillon, Alicia Marquez Garcia, et al.
Pulmonary Circulation|April 27, 2026
Treprostinil Is Associated With Early and Sustained Improvement in Group 3 Pulmonary Hypertension and Right Ventricular Function in ChildrenKaushik Parvathaneni, Justin J Kochanski, Megha D Tandel, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|August 9, 2023
Pulmonary Vasodilator Therapy in Pediatric Patients on Ventricular Assist Device Support: A Single-Center Experience and Proposal for UseJennifer E Schramm, John C Dykes, Rachel K Hopper, et al.
Journal of Clinical Monitoring and Computing|January 21, 2019
Pulmonary lung Doppler signals: normative data in a pediatric population compared with adultsDanielle S Burstein, Rachel K Hopper, Elisa K McCarthy, et al.
The Journal of Pediatrics|March 12, 2019
Histopathologic and Genetic Features of Alveolar Capillary Dysplasia with Atypical Late Presentation and Prolonged SurvivalJonathan J Edwards, Chaya Murali, Jennifer Pogoriler, et al.
Pageof 6

Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
American Journal of Medical Genetics. Part A|February 24, 2015
Neonatal pulmonary arterial hypertension and Noonan syndrome: two fatal cases with a specific RAF1 mutationRachel K Hopper, Jeffrey A Feinstein, Melanie A Manning, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 12, 2017
Subcutaneous treprostinil in pediatric patients with failing single-ventricle physiologyStephanie S Handler, Michelle T Ogawa, Rachel K Hopper, et al.
Pulmonary Circulation|January 9, 2018
Central line replacement following infection does not improve reinfection rates in pediatric pulmonary hypertension patients receiving intravenous prostanoid therapyElisa K McCarthy, Michelle T Ogawa, Rachel K Hopper, et al.
Pulmonary Circulation|February 13, 2024
Younger age at initiation of subcutaneous treprostinil is associated with better response in pediatric Group 1 pulmonary arterial hypertensionJustin J Kochanski, Jeffrey A Feinstein, Michelle Ogawa, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|February 16, 2026
Results of a pulmonary hypertension screening program for premature infants with bronchopulmonary dysplasiaRamya Ramachandra, Alisa Arunamata, Amanda Moy, et al.
Pulmonary Circulation|April 15, 2025
Importance of age at diagnosis of pulmonary hypertension in children living at high altitude: Longitudinal follow-up of 86 patientsGabriel F Diaz, Carlos E Diaz-Castrillon, Alicia Marquez Garcia, et al.
Pulmonary Circulation|April 27, 2026
Treprostinil Is Associated With Early and Sustained Improvement in Group 3 Pulmonary Hypertension and Right Ventricular Function in ChildrenKaushik Parvathaneni, Justin J Kochanski, Megha D Tandel, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|August 9, 2023
Pulmonary Vasodilator Therapy in Pediatric Patients on Ventricular Assist Device Support: A Single-Center Experience and Proposal for UseJennifer E Schramm, John C Dykes, Rachel K Hopper, et al.
Journal of Clinical Monitoring and Computing|January 21, 2019
Pulmonary lung Doppler signals: normative data in a pediatric population compared with adultsDanielle S Burstein, Rachel K Hopper, Elisa K McCarthy, et al.
The Journal of Pediatrics|March 12, 2019
Histopathologic and Genetic Features of Alveolar Capillary Dysplasia with Atypical Late Presentation and Prolonged SurvivalJonathan J Edwards, Chaya Murali, Jennifer Pogoriler, et al.
Pageof 6